Protection from hepatic ischemia/reperfusion injury and improvement of liver regeneration by α-lipoic acid

Shock

Volumn 27, Issue 6, 2007, Pages 644-651

  Duenschede, Friedrich ^a   Erbes, Kirsten ^a   Kircher, Achim ^a   Westermann, Stefanie ^a   Schad, Arno ^a   Riegler, Nina ^a   Ewald, Patrick ^a   Dutkowski, Philipp ^b   Kiemer, Alexandra K ^c   Kempski, Oliver ^a   Junginger, Theodor ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c SAARLAND UNIVERSITY   (Germany)

Author keywords

Apoptosis; Ischemic tolerance; Liver failure; Liver surgery; Preconditioning of the liver

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; KI 67 ANTIGEN; THIOCTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VIVO STUDY; INFERIOR CAVA VEIN; ISCHEMIC PRECONDITIONING; LIVER CELL MEMBRANE; LIVER INJURY; LIVER ISCHEMIA; LIVER NECROSIS; LIVER PERFUSION; LIVER PROTECTION; LIVER REGENERATION; MALE; MITOSIS INDEX; NICK END LABELING; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; SURVIVAL TIME; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANIMALS; APOPTOSIS; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATOCYTES; IN SITU NICK-END LABELING; KI-67 ANTIGEN; LIVER; LIVER REGENERATION; MALE; MITOCHONDRIA; RATS; REPERFUSION INJURY; THIOCTIC ACID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34248999509     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000248582.25647.ee     Document Type: Article

References (39)

1. Wobbes T, Bemelmanns B, Kuypers JH, Beerthuizen GI, Theeuwes AG: Risk of postoperative septic complications after abdominal surgery treatment in relation to perioperative blood transfusion. Surg Gynecol Obstet 171:59-62, 1990.
2. Cowan RE, Jackson BT, Grainger SL, Thompson R: Effects of anesthetic agents and abdominal surgery on liver blood flow. Hepatology 14:1161-1166, 1991.
3. Huguet C, Gavelli A, Bona S: Hepatic resection with ischemia of the liver exceeding one hour. J Am Coll Surg 178:454-458, 1994.
4. Trump BF, Goldblatt PJ, Stowell RE: Studies of necrosis in vitro of mouse hepatic parenchymal cells. Ultrastructural alterations in endoplasmic reticulum, Golgi apparatus, plasma membrane and lipid droplets. Lab Invest 14: 2000-2028, 1965.
5. Lemasters JJ, Nieminen AL, Herman B: Blebbing, free Ca++ and mitochondrials membrane potential preceding cell death in hepatocytes. Nature 325: 78-81, 1987.
6. Jaeschke H, Bautista AP, Spolarics Z: Superoxide generation by neutrophils and Kupffer cells during in vivo reperfusion after ischemia in rats. J Leukoc Biol 52:377-382, 1994.
7. Suzuki S, Toledo-Pereyra LH: Interleukin 1 and tumor necrosis factor production as the initial stimulants of liver ischemia and reperfusion injury. J Surg Res 57:253-258, 1994.
8. Scales WE, Campbell DA, Green ME, Remick DG: Hepatic ischemia/reperfusion injury: importance of oxidant/tumor necrosis factor interactions. Am J Physiol Gastrointest Liver Physiol 30:G1122-G1127, 1994.
9. Yamada Y, Kirillova I, Peschon JJ, Fausto N: Initiation of liver growth by tumor necrosis factor alpha: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci USA 94:1441-1446, 1997.
10. Giakoustidis D, Papageorgiou G, Iliadis S, Kontos N, Kostopoulou E, Papachrestou A: Intramuscular administration of very high dose of alpha-tocopherol protects liver from severe ischemia/reperfusion injury. World J Surg 26:872-877, 2002.
11. Bilzer M, Baron A, Schauer R, Steib C, Ebensberger S, Gerbes AL: Glutathione treatment protects the rat liver against injury after warm ischemia and Kupffer cell activation. Digestion 66:49-57, 2002.
12. Schemmer P, Bradford BU, Rose LM, Bunzendahl H, Raleigh JA, Lemasters JJ: Intravenous glycine improves survival in rat liver transplantation. Am J Physiol Gastrointest Liver Physiol 276:G924-G932, 1999.
13. Yadav SS, Sindram D, Perry DK, Clavien PA: Ischemic preconditioning protects the mouse liver by inhibition of apoptosis through a caspase-dependent pathway. Hepatology 30:1223-1231, 1999.
14. Eipel C, Glanemann M, Nuessler AK, Menger MD, Neuhaus P, Vollmar B: Ischemic preconditioning impairs liver regeneration in extended reduced-size livers. Ann Surg 241:477-484, 2005.
15. Arivazhagan P, Ramanathan K, Pannerselvam C: Effects of alpha-lipoic acid on glutathione metabolic enzymes in aged rats. Exp Gerontol 37:81-87, 2001.
16. Bastiaans H, Haenen G, Bast A: Interplay between ascorbic acid, alphatocopherol, glutathione and lipoic acid in the protection against microsomal lipid peroxidation. Eur J Pharmacol 183:2436-2437, 1990.
17. Müller C, Dünschede F, Koch E, Vollmar AM, Kiemer AK: Alpha lipoic acid preconditioning reduces ischemia-reperfusion injury of the rat liver via the PI3-kinase/Akt pathway. Am J Physiol Gastrointest Liver Physiol 285: G769-G778, 2003.
18. Trautschold I, Lamprecht W, Schweitzer G: ATP: UV-method with hexokinase and glucose-6-phosphate dehydrogenase. In Bergmeyer, (ed.): Methods of Enzymatic Analysis. Vol. VII. 3rd ed. Hoboken, NJ: John Wiley & Sons, pp 346-357, 1988.
19. Gurtu V, Kain SR, Zhang G: Fluorometric and colorimetric detection of caspase activity associated with apoptosis. Anal Biochem 251:98-102, 1997.
20. Ziegler D, Hanefeld M, Ruhnau J, Meissner HB, Lobisch M, Schutte K, Gries FA: Treatment of symptomatic diabetic peripheral neuropathy with the antioxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia 38:1425-1433, 1995.
21. Suzuki JY, Tsuchiya M, Packer L: Thioctic acid and dihydrolipoic acid are novel antioxidants which interact with reactive oxygen species. Free Radic Res Commun 15:255-263, 1991.
22. Packer L, Witt EH, Tritschler HJ: Alpha lipoic acid as a biological antioxidant. Free Radic Biol Med 19:227-250, 1995.
23. Hermann R: Human Pharmacokinetics of alpha-lipoic acid. In Fuchs J, Packer L, Zimmer G, (eds.): Lipoic Acid in Health and Disease. New York: Marcel-Dekker, pp 337-360, 1997.
24. Peinado J, Sies H, Akerboom TPM: Hepatic lipoate uptake. Arch Biochem Biophys 273:389-395, 1989.
25. Grützner U, Keller M, Bach M, Kiemer AK, Meissner H, Bilzer M, Zahler S, Gerbes AL, Vollmar AM: PI 3-kinase pathway is responsible for antiapoptotic effects of atrial natriuretic peptide in rat liver transplantation. World J Gastroenterol 12:1049-1055, 2006.
26. Zimmer G, Beikler TK, Schneider M, Ibel J, Tritschler H, Ulrich H: Dose/response curves of lipoic acid R- and S-forms in the working rat heart during reoxygenation: superiority of the R-enantiomer in enhancement of aortic flow. J Mol Cell Cardiol 27:1895-1903, 1995.
27. Gaballo A, Zanotti F, Solimeo A, Papa S: Topological and functional relationship of subunits F1-g and F0-I-PVP (b) in the mitochondrial H+ ATP-synthase. Biochemistry 37:17519-17526, 1998.
28. Dünschede F, Zwicker K, Ackermann H, Zimmer G: ADP- and oligomycin-sensitive redox behaviour of F0b thiol in ATP synthase depends on neighbored primary structure: investigation using 14-C-labeled alpha lipoic acid. Biofactors 19:19-32, 2003.
29. Rüdiger HA, Clavien PA: Tumor necrosis factor-alpha, but not Fas, mediates hepatocellular Apoptosis in the murine ischemic liver. Gastroenterology 122:202-210, 2002.
30. Kiemer AK, Vollmar AM: Inhibition of LPS-induced nitric oxide and TNFa production by a-lipoic acid in rat Kupffer cells and in RAW 264.7 murine macrophages. Immunol Cell Biol 80:550-557, 2002.
31. Jürgensmeier JM, Xie Z, Deveraux Q, Ellerby L, Bredesen D, Reed JC: Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci USA 95:4997-5002, 1998.
32. Zhao Y, Li S, Childs EE, Kuharsky DK, Yin XM: Activation of pro-death Bcl-2 family and mitochondria apoptosis pathway in tumor necrosis factor alpha induced liver injury. J Biol Chem 276:27432-27440, 2001.
33. Brambrink MA, Schneider A, Noga H, Astheimer A, Götz B, Körner I, Heimann A, Welschof M, Kempski O: Tolerance-inducing dose of 3-nitropropionic acid modulates bcl-2 and bax balance in the rat brain: a potential mechanism of chemical preconditioning. J Cereb Blood Flow Metab 20:1425-1436, 2000.
34. Pessayre D, Fromenty B, Mansouri A: Mitochondrial injury in steatohepatitis. Eur J Gastroenterol Hepatol 16:1095-1105, 2004.
35. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X: Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiate an apoptotic protease cascade. Cell 91:479-489, 1997.
36. Bossy-Wetzel E, Green DR: Caspase induce cytochrome c release from mitochondria by activating cytosolic factors. J Biol Chem 274:17484-17490, 1999.
37. Duenschede F, Westermann S, Riegler N, Ewald P, Kircher A, Schaefer H, Schneider J, Schad A, Junginger T: Different protection mechanisms after pretreatment with glycine or alpha-lipoic acid in a rat model of warm hepatic ischemia. Eur Surg Res. 38:503-512, 2006.
38. Selzner N, Selzner M, Tian Y, Kadry Z, Clavien PA: Cold ischemia decreases liver regeneration after partial liver transplantation in the rat: a TNF-alpha/IL-6-dependent mechanism. Hepatology 36:812-818, 2002.
39. Dünschede F, Erbes K, Kircher A, Westermann S, Seifert J, Schad A, Kempski O, Kiemer AK, Junginger T: Reduction of ischemia reperfusion injury after liver resection and hepatic inflow occlusion by α-lipoic acid in humans. World J Gastroenterol. 12:6812-6817, 2006.